"Sierra Leone is awaiting the outcome of the WHO panel before pursuing ZMapp, and the country has approached Tekmira about getting access to its product, Sierra Leone Chief Medical Officer Brima Kargbo said today in a telephone interview. "
from Bloomberg article By Caroline Chen and Robert Langreth
O'Dempsey, a doctor with three decades' experience studying and fighting tropical diseases, was seconded to Sierra Leone by the World Health Organization to help battle the biggest outbreak of the deadly hemorrhagic fever in history.
Many epidemiologists and infectious disease specialists - including O'Dempsey, a senior lecturer at the Liverpool School of Tropical Medicine - fear it could get far worse.
"It's unlikely we've seen the peak," he said. A lot more needs to be done to improve and expand treatment facilities to ensure all patients who need to be contained and isolated can be, and to make sure fear and stigma were not made worse, he added.
Reuters By Kate Kelland
"Hearing the news, the Nigerian government asked the U.S. Centers for Disease Control and Prevention for access to the drug, The Guardian reported. But the CDC responded that there are virtually no doses of ZMapp left, meaning that West African nations would have to wait several months for new supplies of the untested drug to be generated."
CBS News by Dennis Thompson
US approved the drug ZMapp to be shipped to Liberia for treating infected doctors. Sorry is on CNBC does not mention anything about tekmira. This could be negative for tkmr especially with earnings that will show losses accelerated.